UB Paderborn / Katalog / Suche / in CDI

Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS

Analytical chemistry (Washington), 2003-07, Vol.75 (13), p.3019-3030

2003

Volltextzugriff (PDF)

Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations

Analytical chemistry (Washington), 1998-03, Vol.70 (5), p.882-889

1998

Volltextzugriff (PDF)

Determination of dextromethorphan and its metabolite dextrorphan in human urine using high performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry: a study of selectivity of a tandem mass spectrometric assay

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005-02, Vol.816 (1), p.297-308

2005

Volltextzugriff (PDF)

Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-08, Vol.807 (2), p.243-250

2004

Volltextzugriff (PDF)

Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

Journal of pharmaceutical and biomedical analysis, 2004-09, Vol.35 (5), p.1213-1229

2004

Volltextzugriff (PDF)

Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection

Journal of pharmaceutical and biomedical analysis, 2002-06, Vol.28 (5), p.925-934

2002

Volltextzugriff (PDF)

Determination of a cyclooxygenase II inhibitor in human plasma by capillary gas chromatography with mass spectrometric detection

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-06, Vol.805 (1), p.21-25

2004

Volltextzugriff (PDF)

Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2016-02, Vol.1011, p.204-214

2016

Volltextzugriff (PDF)

High-performance liquid chromatographic–tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2002-02, Vol.767 (1), p.117-129

2002

Volltextzugriff (PDF)

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D₃ in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-05, Vol.879 (17-18), p.1457-1466

2011

Volltextzugriff (PDF)

Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques

Drug metabolism and disposition, 2001-12, Vol.29 (12), p.1614

2001

Volltextzugriff (PDF)

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D 3 in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-05, Vol.879 (17), p.1457-1466

2011

Volltextzugriff (PDF)

Cyclobenzaprine Pharmacokinetics, Including the Effects of Age, Gender, and Hepatic Insufficiency

Journal of clinical pharmacology, 2002-01, Vol.42 (1), p.61-69

2002

Volltextzugriff (PDF)

Determination of Rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

Journal of chromatography. B, Biomedical sciences and applications, 2000-10, Vol.748 (1), p.31-39

2000

Volltextzugriff (PDF)

Development of high-performance liquid chromatography–tandem mass spectrometric methods for the determination of a new oxytocin receptor antagonist (L-368,899) extracted from human plasma and urine: a case of lack of specificity due to the presence of metabolites

Journal of chromatography. B, Biomedical sciences and applications, 1998-09, Vol.716 (1), p.195-208

1998

Volltextzugriff (PDF)

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D sub(3 in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME)

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011-05, Vol.879 (17-18), p.1457-1466

2011

Volltextzugriff (PDF)

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D3 in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME: ENHANCEMENT OF ANALYSIS BY ANALYTICAL DERIVATIZATION

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Vol.879 (17-18), p.1457-1466

2011

Volltextzugriff (PDF)

Determination of a novel growth hormone secretagogue (MK-677) in human plasma at picogram levels by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Journal of chromatography. B, Biomedical sciences and applications, 1997-05, Vol.693 (1), p.131-137

1997

Volltextzugriff (PDF)

Picogram determination of a novel dopamine D4 receptor antagonist in human plasma and urine by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Journal of chromatography. B, Biomedical sciences and applications, 1997-03, Vol.691 (1), p.77

1997

Volltextzugriff (PDF)

Determination of a novel selective inhibitor of type 1 5α-reductase in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Journal of chromatography. Biomedical applications, 1998-08, Vol.713 (2), p.371-378

1998

Volltextzugriff (PDF)

Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects

Clinical pharmacology and therapeutics, 2003-02, Vol.73 (2), p.P66-P66

2003

Volltextzugriff (PDF)

Picogram determination of a novel dopamine D4 receptor antagonist in human plasma and urine by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Journal of chromatography. Biomedical applications, 1997-03, Vol.691 (1), p.77-85

1997

Volltextzugriff (PDF)

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Clinical pharmacology and therapeutics, 2008-12, Vol.84 (6), p.679-683

2008

Volltextzugriff (PDF)

Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet

Journal of clinical pharmacology, 2011-10, Vol.51 (10), p.1439-1448

2011

Volltextzugriff (PDF)

Determination of a thermally labile metabolite of a novel growth hormone secretagogue in human and dog plasma by liquid chromatography with ion spray tandem mass spectrometric detection

Journal of chromatography. B, Biomedical sciences and applications, 2001-08, Vol.760 (1), p.45-53

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC−MS/MS

Matrix Effect in Quantitative LC/MS/MS Analyses of Biological Fluids: A Method for Determination of Finasteride in Human Plasma at Picogram Per Milliliter Concentrations

Determination of dextromethorphan and its metabolite dextrorphan in human urine using high performance liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry: a study of selectivity of a tandem mass spectrometric assay

Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors

Simultaneous determination of Aprepitant and two metabolites in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

Determination of efavirenz, a selective non-nucleoside reverse transcriptase inhibitor, in human plasma using HPLC with post-column photochemical derivatization and fluorescence detection

Determination of a cyclooxygenase II inhibitor in human plasma by capillary gas chromatography with mass spectrometric detection

Quantitation of anacetrapib, stable-isotope labeled-anacetrapib (microdose), and four metabolites in human plasma using liquid chromatography tandem mass spectrometry

High-performance liquid chromatographic–tandem mass spectrometric evaluation and determination of stable isotope labeled analogs of rofecoxib in human plasma samples from oral bioavailability studies

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D₃ in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME

Mechanistic studies on the reversible metabolism of rofecoxib to 5-hydroxyrofecoxib in the rat: evidence for transient ring opening of a substituted 2-furanone derivative using stable isotope-labeling techniques

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D 3 in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME

Cyclobenzaprine Pharmacokinetics, Including the Effects of Age, Gender, and Hepatic Insufficiency

Determination of Rofecoxib (MK-0966), a cyclooxygenase-2 inhibitor, in human plasma by high-performance liquid chromatography with tandem mass spectrometric detection

Development of high-performance liquid chromatography–tandem mass spectrometric methods for the determination of a new oxytocin receptor antagonist (L-368,899) extracted from human plasma and urine: a case of lack of specificity due to the presence of metabolites

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D sub(3 in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME)

Quantitative liquid chromatographic and tandem mass spectrometric determination of vitamin D3 in human serum with derivatization: A comparison of in-tube LLE, 96-well plate LLE and in-tip SPME: ENHANCEMENT OF ANALYSIS BY ANALYTICAL DERIVATIZATION

Determination of a novel growth hormone secretagogue (MK-677) in human plasma at picogram levels by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Picogram determination of a novel dopamine D4 receptor antagonist in human plasma and urine by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Determination of a novel selective inhibitor of type 1 5α-reductase in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Lack of effect of aprepitant on digoxin pharmacokinetics in healthy subjects

Picogram determination of a novel dopamine D4 receptor antagonist in human plasma and urine by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry

Multiple-Dose Pharmacodynamics and Pharmacokinetics of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Subjects

Bioavailability of alendronate and vitamin D(3) in an alendronate/vitamin D(3) combination tablet

Determination of a thermally labile metabolite of a novel growth hormone secretagogue in human and dog plasma by liquid chromatography with ion spray tandem mass spectrometric detection

Suchergebnisse filtern